SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pancho Villa who wrote (956)12/25/1997 2:58:00 PM
From: Pancho Villa  Read Replies (2) of 1359
 
From the FY97 results press release:

"Consolidated selling, general and administrative expenses increased to $24,890,000 in fiscal 1997, from $17,167,000 in fiscal 1996. This increase primarily reflects costs related to the Redux sales force, regional test marketing and preparation for the national launch of PMS Escape, expansion of facilities at Interneuron, INCREASED USE OF CONSULTANTS, and market research in connection with CerAxon. Consolidated selling, general and administrative costs for the three-month period ended September 30, 1997 totaled $6,174,000, compared to $5,989,000 for the three-month period ended September 30, 1996."

Interesting... my remark in previous post was made before reading the release in detail. IMO burning/grabbing as much of the cash seems to be the name of the game from now on. $140 million [or whatever is left by now] is a lot of dough better use it up than have it end up in the pockets of litigation lawyers.

Pancho
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext